Huan‐Qiu Li

3.2k total citations
68 papers, 2.4k citations indexed

About

Huan‐Qiu Li is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Huan‐Qiu Li has authored 68 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Organic Chemistry, 27 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Huan‐Qiu Li's work include Synthesis and biological activity (21 papers), HER2/EGFR in Cancer Research (9 papers) and Quinazolinone synthesis and applications (7 papers). Huan‐Qiu Li is often cited by papers focused on Synthesis and biological activity (21 papers), HER2/EGFR in Cancer Research (9 papers) and Quinazolinone synthesis and applications (7 papers). Huan‐Qiu Li collaborates with scholars based in China, United States and Canada. Huan‐Qiu Li's co-authors include Hai‐Liang Zhu, Lei Shi, Peng‐Cheng Lv, Tao Yan, Yang Zhou, Peng‐Cheng Lv, Zhu‐Ping Xiao, Hui Ming Ge, Juan Sun and Renxiang Tan and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Dalton Transactions.

In The Last Decade

Huan‐Qiu Li

65 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huan‐Qiu Li China 27 1.4k 837 502 204 177 68 2.4k
Sumera Zaib Pakistan 33 1.9k 1.4× 1.1k 1.3× 400 0.8× 409 2.0× 252 1.4× 150 3.3k
Carmen Sanmartín Spain 37 1.8k 1.3× 832 1.0× 286 0.6× 210 1.0× 139 0.8× 154 3.9k
Zhu‐Ping Xiao China 24 876 0.6× 545 0.7× 273 0.5× 156 0.8× 155 0.9× 67 1.7k
Łukasz Berlicki Poland 26 1.7k 1.2× 1.4k 1.6× 550 1.1× 70 0.3× 285 1.6× 93 3.0k
Imtiaz Khan Pakistan 35 3.2k 2.3× 1.2k 1.4× 176 0.4× 330 1.6× 509 2.9× 129 4.4k
Juan Antonio Palop Spain 32 1.6k 1.2× 604 0.7× 222 0.4× 133 0.7× 110 0.6× 97 2.9k
Maliheh Safavi Iran 34 1.6k 1.1× 1.0k 1.2× 234 0.5× 517 2.5× 66 0.4× 140 3.2k
Gamal El‐Din A. Abuo‐Rahma Egypt 31 2.1k 1.5× 1.3k 1.6× 340 0.7× 379 1.9× 41 0.2× 120 3.1k
Hazem A. Ghabbour Saudi Arabia 35 3.1k 2.3× 1.3k 1.5× 480 1.0× 379 1.9× 283 1.6× 348 4.3k
Gerrit J. Poelarends Netherlands 41 1.3k 0.9× 2.5k 3.0× 410 0.8× 251 1.2× 265 1.5× 159 4.5k

Countries citing papers authored by Huan‐Qiu Li

Since Specialization
Citations

This map shows the geographic impact of Huan‐Qiu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan‐Qiu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan‐Qiu Li more than expected).

Fields of papers citing papers by Huan‐Qiu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan‐Qiu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan‐Qiu Li. The network helps show where Huan‐Qiu Li may publish in the future.

Co-authorship network of co-authors of Huan‐Qiu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Huan‐Qiu Li. A scholar is included among the top collaborators of Huan‐Qiu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan‐Qiu Li. Huan‐Qiu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ao, Gui‐Zhen, et al.. (2016). Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents. Bioorganic & Medicinal Chemistry. 25(1). 166–174. 34 indexed citations
2.
Li, Sining, Yunyun Xu, Jiayu Gao, et al.. (2015). Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry. 23(13). 3221–3227. 26 indexed citations
3.
Li, Sining & Huan‐Qiu Li. (2014). Epidermal growth factor receptor inhibitors: a patent review (2010 – present). Expert Opinion on Therapeutic Patents. 24(3). 309–321. 19 indexed citations
4.
Xu, Yunyun, et al.. (2012). Design, synthesis and molecular docking of α,β-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferative activity. Bioorganic & Medicinal Chemistry. 21(2). 388–394. 44 indexed citations
5.
Li, Huan‐Qiu, Dong‐Dong Li, Xiang Lu, Yunyun Xu, & Hai‐Liang Zhu. (2011). Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity. Bioorganic & Medicinal Chemistry. 20(1). 317–323. 35 indexed citations
6.
Lv, Peng‐Cheng, Huan‐Qiu Li, Juan Sun, Yang Zhou, & Hai‐Liang Zhu. (2010). Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents. Bioorganic & Medicinal Chemistry. 18(13). 4606–4614. 244 indexed citations
7.
Luo, Yin, Huan‐Qiu Li, Yang Zhou, et al.. (2010). Metronidazole–Deoxybenzoin Derivatives as Anti‐Helicobacter pylori Agents with Potent Inhibitory Activity against HPE‐Induced Interleukin‐8. ChemMedChem. 5(7). 1110–1116. 13 indexed citations
8.
Li, Huan‐Qiu, Yin Luo, Peng‐Cheng Lv, et al.. (2010). Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters. 20(6). 2025–2028. 24 indexed citations
9.
Zheng, Qing‐Zhong, Fei Zhang, Kui Cheng, et al.. (2009). Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents. Bioorganic & Medicinal Chemistry. 18(2). 880–886. 20 indexed citations
10.
Lv, Peng‐Cheng, Changfang Zhou, Jin Chen, et al.. (2009). Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 18(1). 314–319. 119 indexed citations
11.
Li, Huan‐Qiu, Yin Luo, Dong‐Dong Li, & Hai‐Liang Zhu. (2009). (E)-4-Chlorobenzyl 3-(3-nitrobenzylidene)dithiocarbazate. Acta Crystallographica Section E Structure Reports Online. 65(12). o3101–o3101. 2 indexed citations
12.
13.
Huang, Xianfeng, Huan‐Qiu Li, Lei Shi, et al.. (2008). Synthesis of Resveratrol Analogues, and Evaluation of Their Cytotoxic and Xanthine Oxidase Inhibitory Activities. Chemistry & Biodiversity. 5(4). 636–642. 21 indexed citations
14.
Lv, Peng‐Cheng, Huan‐Qiu Li, Jia‐Yu Xue, Lei Shi, & Hai‐Liang Zhu. (2008). Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. European Journal of Medicinal Chemistry. 44(2). 908–914. 80 indexed citations
15.
Huang, Xianfeng, Hui Ding, Hui Ming Ge, et al.. (2007). Synthesis and Cytotoxic Evaluation of Substituted Urea Derivatives as Inhibitors of Human‐Leukemia K562 Cells. Chemistry & Biodiversity. 4(5). 881–886. 26 indexed citations
16.
Kaila, Neelu, Neal Green, Huan‐Qiu Li, et al.. (2007). Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitriles. Bioorganic & Medicinal Chemistry. 15(19). 6425–6442. 23 indexed citations
17.
Xiao, Zhu‐Ping, Da‐Hua Shi, Huan‐Qiu Li, et al.. (2007). Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease. Bioorganic & Medicinal Chemistry. 15(11). 3703–3710. 121 indexed citations
19.
Li, Huan‐Qiu, Hui Ming Ge, Chen Xu, et al.. (2006). Synthesis and Cytotoxic Evaluation of a Series of Genistein Derivatives. Chemistry & Biodiversity. 3(4). 463–472. 21 indexed citations
20.
Yang, Yumin, Huan‐Qiu Li, Lei Shi, & Hai‐Liang Zhu. (2005). Iodometronidazole. Acta Crystallographica Section E Structure Reports Online. 61(9). o2882–o2883. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026